Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Satish Chandra Kilaru, Avya Gopal Bansal, Vaishali Sandeep Naik, Meena Lopez & Jaideep Ashok Gogtay. (2022) A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination. Expert Review of Respiratory Medicine 16:5, pages 529-540.
Read now
Read now
Shiyuan Zhang, Denise King, Virginia M Rosen & Afisi S Ismaila. (2020) Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 417-438.
Read now
Read now
A Papi, D Dokic, W Tzimas, I Mészáros, A Olech-Cudzik, Z Koroknai, K McAulay, S Mersmann, PS Dalvi & T Overend. (2017) Fluticasone propionate/formoterol for COPD management: a randomized controlled trial. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1961-1971.
Read now
Read now
Theresa R Prosser & Suzanne G Bollmeier. (2015) Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma. Therapeutics and Clinical Risk Management 11, pages 889-899.
Read now
Read now
Ricardo Antonio Tan & Jonathan Corren. (2014) Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma. Drug Design, Development and Therapy 8, pages 1555-1561.
Read now
Read now
David Price & Elizabeth V Hillyer. (2014) Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma. Expert Review of Respiratory Medicine 8:3, pages 275-291.
Read now
Read now
Articles from other publishers (24)
Yuji Oba, Sumayya Anwer, Tarang Patel, Tinashe Maduke & Sofia Dias. (2023) Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2023:8.
Crossref
Crossref
Sanjeeva Dissanayake, Gill MundinJo WoodwardMark LomaxPrashant Dalvi. (2023) Pharmacokinetic and Pharmacodynamic Comparison of Fluticasone Propionate/Formoterol Fumarate Administered via a Pressurized Metered-Dose Inhaler and a Novel Breath-Actuated Inhaler in Healthy Volunteers. Journal of Aerosol Medicine and Pulmonary Drug Delivery 36:2, pages 65-75.
Crossref
Crossref
Iain Crossingham, Sally Turner, Sanjay Ramakrishnan, Anastasia Fries, Matthew Gowell, Farhat Yasmin, Rebekah Richardson, Philip Webb, Emily O'Boyle & Timothy SC Hinks. (2021) Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database of Systematic Reviews 2021:5.
Crossref
Crossref
David B. Price, Victoria Carter, Jessica Martin, Elizabeth A. Gardener, Derek Skinner, Sen Yang, Matthias Hoffman, Jenna C. Willis & Andrew J. Cooper. (2019) Comparative Safety Profile of the Fixed-Dose Combination Corticosteroid and Long-acting β2-Agonist Fluticasone Propionate/Formoterol Fumarate: A 36-Month Longitudinal Cohort Study in UK Primary Care. Drugs 80:1, pages 47-60.
Crossref
Crossref
Chengzhi Zhang & Guiying Yan. (2019) Synergistic drug combinations prediction by integrating pharmacological data. Synthetic and Systems Biotechnology 4:1, pages 67-72.
Crossref
Crossref
Murugesh Shivashankar & Mani Dhandayuthapani. (2019) A study of Inhalation Drugs in the Management of Asthma in Northern Parts of Tamilnadu. Materials Today: Proceedings 15, pages 268-272.
Crossref
Crossref
Dominik Kappeler, Knut Sommerer, Claudius Kietzig, Bärbel Huber, Jo Woodward, Mark Lomax & Prashant Dalvi. (2018) Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler. Respiratory Medicine 138, pages 107-114.
Crossref
Crossref
Vibeke Backer, Adam Ellery, Sylvia Borzova, Stephen Lane, Magda Kleiberova, Peter Bengtsson, Tadeusz Tomala, Dominique Basset-Stheme, Carla Bennett, Dirk Lindner, Arthur Meiners & Tim Overend. (2018) Non-interventional study of the safety and effectiveness of fluticasone propionate/formoterol fumarate in real-world asthma management. Therapeutic Advances in Respiratory Disease 12, pages 175346661879698.
Crossref
Crossref
Anna Płoszczuk, Miroslava Bosheva, Kay Spooner, Tammy McIver & Sanjeeva Dissanayake. (2018) Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial. Therapeutic Advances in Respiratory Disease 12, pages 175346661877792.
Crossref
Crossref
David BellLucielle MansfieldMark Lomax. (2017) A Randomized, Crossover Trial Evaluating Patient Handling, Preference, and Ease of Use of the Fluticasone Propionate/Formoterol Breath-Triggered Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery 30:6, pages 425-434.
Crossref
Crossref
Simon Wan Yau Ming, John Haughney, Iain Small, Stephanie Wolfe, John Hamill, Kevin Gruffydd-Jones, Cathal Daly, Joan B. Soriano, Elizabeth Gardener, Derek Skinner, Martina Stagno d'Alcontres & David B. Price. (2017) Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation. Respiratory Medicine 129, pages 199-206.
Crossref
Crossref
Fabio Arpinelli, Mauro Carone, Gioacchino Riccardo & Giorgio Bertolotti. (2016) Health-related quality of life measurement in asthma and chronic obstructive pulmonary disease: review of the 2009-2014 literature. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Alberto PapiAdel H. MansurTetyana PertsevaKirsten KaiserTammy McIverBirgit GrotheSanjeeva Dissanayake. (2016) Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations. Journal of Aerosol Medicine and Pulmonary Drug Delivery 29:4, pages 346-361.
Crossref
Crossref
René Aalbers, Claus Vogelmeier & Piotr Kuna. (2016) Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention. Respiratory Medicine 111, pages 1-7.
Crossref
Crossref
J.A. Quintano Jiménez, L. Ginel Mendoza, L.M. Entrenas Costa & J. Polo García. (2016) Combinación a dosis fija de fluticasona propionato/formoterol fumarato para el tratamiento del asma: una revisión de la farmacología, eficacia y tolerabilidad. SEMERGEN - Medicina de Familia 42, pages 2-9.
Crossref
Crossref
Alberto Papi & Mario Cazzola. (2015) Combination treatment in asthma: Reviewing old and new options. Pulmonary Pharmacology & Therapeutics 34, pages 72-74.
Crossref
Crossref
M. Latorre, P. Paggiaro, W. Canonica, M.P. Foschino & A. Papi. (2015) A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler. Pulmonary Pharmacology & Therapeutics 34, pages 31-36.
Crossref
Crossref
Nicola Scichilone, Andrea Rossi & Andrea Melani. (2015) Revising old principles of inhaled treatment in new fixed combinations for asthma. Pulmonary Pharmacology & Therapeutics 33, pages 32-38.
Crossref
Crossref
Haley M. Hoy & Louise C. O'Keefe. (2015) Practical guidance on the recognition of uncontrolled asthma and its management. Journal of the American Association of Nurse Practitioners 27:8, pages 466-475.
Crossref
Crossref
Alberto Papi, David Price, Joaquin Sastre, Kirsten Kaiser, Mark Lomax, Tammy McIver & Sanjeeva Dissanayake. (2015) Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis. Respiratory Medicine 109:2, pages 208-217.
Crossref
Crossref
P. Devillier, H. Salvator, S. Grassin-Delyle, E. Naline, C. Advenier & N. Roche. (2014) Une nouvelle association fixe de fluticasone/formotérol dans un aérosol-doseur pressurisé pour le traitement de l’asthme. Revue des Maladies Respiratoires 31:8, pages 700-713.
Crossref
Crossref
A. Papi, F. Blasi, G.W. Canonica, M. Cazzola, S. Centanni, M.P. Foschino Barbaro, A.S. Melani, P. Paggiaro, F. Ricciardolo, A. Rossi & N. Scichilone. (2014) Fluticasone propionate/formoterol: A fixed-combination therapy with flexible dosage. European Journal of Internal Medicine 25:8, pages 695-700.
Crossref
Crossref
Gillian M. Keating & Kate McKeage. (2013) Fluticasone propionate/formoterol fumarate: a guide to its use in persistent asthma. Drugs & Therapy Perspectives 29:11, pages 342-347.
Crossref
Crossref
A. Cukier, C.M.A. Jacob, N.A. Rosario Filho, J. Fiterman, E.O. Vianna, J.L. Hetzel, M.A. Neis, E. Fiss, F.F.M. Castro, A.L.G. Fernandes, R. Stirbulov & E. Pizzichini. (2013) Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma. Respiratory Medicine 107:9, pages 1330-1338.
Crossref
Crossref